Stock Footage0:30
Getty Images

reflection in water

Pre-K - Higher Ed
reflection in water
Stock Footage0:30
Getty Images

backgrounds

Pre-K - Higher Ed
backgrounds
News Clip5:30
Bloomberg

The Ignored Part of the Sharpe Ratio

Higher Ed
Jun.08 -- Barry Ritholtz, a Bloomberg Opinion columnist, discusses return-based versus volatility-based investing with Bloomberg's Tom Keene and Romaine Bostick on "Bloomberg Surveillance." Ritholtz's opinions are his own.
News Clip4:31
Bloomberg

Omicron Has Developed a 'Sister Virus': Johns Hopkins

Higher Ed
Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz discusses the discovery of an evolution of the omicron variant and looking forward to a time where masks will not need to be worn in public. The...
News Clip4:44
Press Association

Surrey Council prepare for Woking testing drive

Higher Ed
Tests are loaded into vans for distribution ahead of days of canvassing local homes in Woking to test for the South African variant of Covid-19, following two cases being identified in the area. The local council is hoping to test 9,500...
News Clip8:51
Bloomberg

How Citi Is Supporting the Global Vaccine Rollout

Higher Ed
Jul.07 -- Jay Collins, vice chairman of banking, capital markets and advisory at Citigroup Inc., discusses the bank's partnership with Gavi, the Vaccine Alliance, to aid in the procurement and equitable distribution of Covid-19 vaccines...
News Clip4:52
Bloomberg

Variants Don’t Pose Great Risk to Vaccinated: Johns Hopkins

Higher Ed
May.21 -- Johns Hopkins Professor of Infectious Diseases Stuart Ray discusses progress made in understanding Covid-19 and concerns about variants. The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and...
News Clip4:22
Bloomberg

Covid Variant From India Triggers WHO Concern

Higher Ed
May.10 -- A fast-spreading strain of Covid-19 first identified in India will be classified as a variant of concern by the World Health Organization. The global health group will publish a detailed report on the variant, called B.1.617,...
News Clip10:22
Bloomberg

Will Vaccines Protect Us From All Covid-19 Variants?

Higher Ed
Apr.19 -- Dr. Robert Gallo, co-founder of the Global Virus Network and director of the Institute of Human Virology at the University of Maryland School of Medicine, discusses the global rollout of Covid-19 vaccines. Global cases passed...
News Clip8:57
Bloomberg

When Will the World Have Enough Covid Vaccines?

Higher Ed
Feb.08 -- Jerome Kim, director general of the International Vaccine Institute, a Seoul-based non-profit international organization devoted to research in vaccine development and delivery for the developing world, discusses the rollout of...
News Clip4:28
Bloomberg

German Court Dismisses Challenge Against EU's Pandemic Recovery Fund

Higher Ed
Apr.21 -- Columbia Threadneedle Investments Head of Multi-Asset Strategy Anwiti Bahuguna speaks to Bloomberg's Alix Steel and Guy Johnson about German Court's decision to dismiss the challenge against the EUs pandemic recovery fund on...
News Clip9:19
Bloomberg

Citi's Collins on Investing in Covax

Higher Ed
Jul.07 -- Jay Collins, Citi Vice Chairman for Banking, Capital Markets and Advisory, discusses how to convince investors to invest in COVAX as global virus cases top 184.7 million. He speaks with Bloomberg's Alix Steel and Guy Johnson on...
News Clip4:21
Bloomberg

Moderna Covid Booster Shots Prove Effective Against Variants

Higher Ed
May.05 -- Moderna's mid-stage trials show its booster vaccine shots were effective against strains of the coronavirus that emerged from Brazil and South Africa. Moderna co-founder Noubar Afeyan speaks exclusively with Bloomberg...
News Clip6:58
Bloomberg

Moderna Works on Vaccines to Get Ahead of Covid-19 Variants

Higher Ed
Apr.06 -- Noubar Afeyan, co-founder at Moderna Inc and CEO at Flagship Pioneering Inc, discusses the new finding that their Covid-19 vaccine still works at least six months after patients get the second dose. He shares how soon he thinks...
News Clip7:35
Bloomberg

Novavax Covid Shot Shows Strong Efficacy Against Variants

Higher Ed
Jun.14 -- Novavax says its vaccine candidate was 90% effective at preventing symptomatic Covid and 100% effective at preventing moderate and severe symptoms in a large trial. The shot was 93% effective against variants. CEO Stanley Erck...
News Clip3:06
Curated Video

Oberoi Group re-opens Trident hotel for 1st time since militant attacks

Higher Ed
1. Exterior of Oberoi's Trident hotel 2. Various of armed police officer at hotel entrance 3. Staff welcoming guests in hotel lobby 4. Trident hotel President Rattan Keswani and Trident hotel Vice President Devendra Bharma take seats...
News Clip6:31
Bloomberg

Lower-Dose Regeneron Antibody Cocktail Is 'Game-Changing': CSO

Higher Ed
Mar.23 -- Regeneron Pharmaceuticals' Covid-19 antibody cocktail showed early use of the drug reduced hospitalizations and deaths by 70% in a final-stage trial. Regeneron's co-founder and chief scientific officer Dr. George Yancopoulos...
News Clip3:13
Bloomberg

U.S. Warned on Covid Variant Even as Cases Slow Sharply

Higher Ed
Feb.07 -- The U.S. added 106,570 Covid-19 cases, almost 8,000 fewer than the week’s previous low, suggesting that the declining trend in infections is continuing. Even so, a new study warns of “further surges” in the U.S. as the...
News Clip13:39
Bloomberg

BofA CEO Moynihan on Inflation Risk, Returning to Office

Higher Ed
Jun.17 -- Bank of America Chairman and CEO Brian Moynihan discusses the state of the U.S. economy, inflation risks and the bank's plan to return employees to their offices. He speaks with Bloomberg's David Westin on "Bloomberg...
News Clip3:16
Bloomberg

Covid-19 Has 5 or 6 Variants of Concern: Johns Hopkins

Higher Ed
Feb.05 -- Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz discusses known variants of the coronavirus and modeling of global vaccination rates. He speaks with Bloomberg’s Francine Lacqua on...
News Clip5:05
Bloomberg

U.K. Records 15 Million Vaccinations Against Coronavirus

Higher Ed
Feb.15 -- Oksana Pyzik, global health adviser and lecturer at University College London, discusses the U.K. hitting its first target for immunizing its top 4 priority groups, with more than 15 million doses now administered. She also...
News Clip2:09
AFP News Agency

CLEAN : "Government has dropped the ball": South Africans react to vaccine rollout suspension

9th - Higher Ed
South Africans react to their government's decision to suspend the rollout of the AstraZeneca Covid-19 vaccine (Footage by AFPTV via Getty Images)
News Clip5:46
Bloomberg

'We Are Still in the Eye of the Storm,' Says Airbus CEO

Higher Ed
Jan.28 -- "We are still in the eye of the storm," Airbus CEO Guillaume Faury said, when discussing the company's pandemic recovery. Faury said the company has learned lessons from 2020 and said that delaying their ramp up shows that the...
News Clip2:55
Sky News

Downing Street Daily Press Briefing on Coronavirus

Higher Ed
CLEAN: Shows interior shots Downing Street Press room with UK Prime Minister Boris Johnson and UK's Chief Scientific Adviser Sir Patrick Valance answering questions during press briefing (part 10). The vaccination programme provides the...